However, an early report suggested a positive relationship between TIMP-3 promoter methylation and better survival in lung cancer patients [21], and high TIMP-3 expression has been linked to an unfavorable prognosis in head and neck cancer [22]. The gene discussed is TIMP3; the disease is lung cancer.